Your browser doesn't support javascript.
loading
Activity-regulated cytoskeleton-associated protein/activity-regulated gene 3.1 (Arc/Arg3.1) enhances dendritic cell vaccination in experimental melanoma.
Zhang, Xin-Wen; Huck, Katrin; Jähne, Kristine; Cichon, Frederik; Sonner, Jana K; Ufer, Friederike; Bauer, Simone; Woo, Marcel Seungsu; Green, Ed; Lu, Kevin; Kilian, Michael; Friese, Manuel A; Platten, Michael; Sahm, Katharina.
Affiliation
  • Zhang XW; Department of Neurology, Mannheim Medical Center, University of Heidelberg, Mannheim, Germany.
  • Huck K; DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.
  • Jähne K; Department of Neurology, Mannheim Medical Center, University of Heidelberg, Mannheim, Germany.
  • Cichon F; DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.
  • Sonner JK; Department of Neurology, Mannheim Medical Center, University of Heidelberg, Mannheim, Germany.
  • Ufer F; DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.
  • Bauer S; Department of Neurology, Mannheim Medical Center, University of Heidelberg, Mannheim, Germany.
  • Woo MS; DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.
  • Green E; Department of Neurology, Mannheim Medical Center, University of Heidelberg, Mannheim, Germany.
  • Lu K; DKTK Clinical Cooperation Unit Neuroimmunology and Brain Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.
  • Kilian M; Institute of Neuroimmunology Und Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Friese MA; Institute of Neuroimmunology Und Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Platten M; Institute of Neuroimmunology Und Multiple Sclerosis, Center for Molecular Neurobiology Hamburg, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Sahm K; Department of Neurology, Mannheim Medical Center, University of Heidelberg, Mannheim, Germany.
Oncoimmunology ; 10(1): 1920739, 2021 05 14.
Article in En | MEDLINE | ID: mdl-34026332
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / Cancer Vaccines Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Oncoimmunology Year: 2021 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Melanoma, Experimental / Cancer Vaccines Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Oncoimmunology Year: 2021 Document type: Article Affiliation country: Alemania Country of publication: Estados Unidos